• Cost Savings:  Drug development costs are 80% less than those in the U.S., and outsourced manufacturing of drugs and devices can be less than 1/10 the cost;
• Technology:  New, cutting-edge compounds and medical devices are now being developed here, and the technology is unfettered by the U.S.’s conservative political climate; and
• Market Size:  China’s market for healthcare products is growing at 17%+ CAGR, and its population of 1.3 billion people is aging more rapidly than any other country.

Outsourcing manufacturing and support services to China is an obvious area for consideration. But China is also subsidizing the migration from manufacturing to R&D to keep its growth engine humming. In addition, other factors contributing to biotechnology and medical device companies looking to China to leverage their research and development activities include:

• China is subsidizing foreign investment organizations and deregulating venture capital.
• There is a large population of highly-educated scientists in China available at 1/10 of U.S. salaries.
• China’s SFDA has been rapidly moving toward global GLP/GMP standards and clinical approval processes.
• IP protection is improving, with patent laws now compliant with WTO/TRIPS requirements and increased legal enforcement.

Doing business in China is an exciting adventure than can reap significant rewards for those who execute properly and respect cultural differences. To others, it may feel like beating your head against the wall while making little or no progress. The best way to ensure success is to get help. Select a partner who understands China’s rapidly changing biomedical industry and business environment and who can build trusted relationships (guanxi) with your potential partners.

ChinaBio® Consulting, established in 2007 by Centient founder, Greg B. Scott, has established key relationships in China that can help companies identify potential partners and create their own guanxi more quickly.  We have also identified the credible companies leading the R&D charge and that providing outsourced services at significantly lower cost, saving our clients time and effort. 

Incorporating our broad range of business services, ChinaBio® Consulting helps U.S.-based life science companies cut through the noise to identify those opportunities that meet our client’s specific business objectives – whether they are identifying a promising compound, outsourcing GMP manufacturing or investing in promising R&D projects.

Whether it’s outsourced services, R&D partnerships or investment opportunities, Centient can assist clients with:

• Developing a clear China strategy
• Identifying promising opportunities
• Making introductions to companies and officials
• Selecting a partner or supplier
• Performing due diligence
• Addressing provincial and state issues
• Leading contract negotiations
• Recruiting China-based management